These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5881298)

  • 1. Electronic particle counting applied to the determination of lytic activity.
    Kniseley SJ; Throop LJ
    Anal Biochem; 1965 Dec; 13(3):417-25. PubMed ID: 5881298
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of NaC1 in the lysis of Staphylococcus aureus by lysostaphin.
    Schindler CA
    J Gen Microbiol; 1965 Aug; 40(2):199-205. PubMed ID: 5867755
    [No Abstract]   [Full Text] [Related]  

  • 3. PURIFICATION AND PROPERTIES OF LYSOSTAPHIN--A LYTIC AGENT FOR STAPHYLOCOCCUS AUREUS.
    SCHINDLER CA; SCHUHARDT VT
    Biochim Biophys Acta; 1965 Feb; 97():242-50. PubMed ID: 14292833
    [No Abstract]   [Full Text] [Related]  

  • 4. Staphylococcus simulans Recombinant Lysostaphin: Production, Purification, and Determination of Antistaphylococcal Activity.
    Boksha IS; Lavrova NV; Grishin AV; Demidenko AV; Lyashchuk AM; Galushkina ZM; Ovchinnikov RS; Umyarov AM; Avetisian LR; Chernukha MIu; Shaginian IA; Lunin VG; Karyagina AS
    Biochemistry (Mosc); 2016 May; 81(5):502-10. PubMed ID: 27297900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of Polycations on Antibacterial Activity of Lysostaphin].
    Kulikov SN; Khairullin RZ; Varlamov VP
    Prikl Biokhim Mikrobiol; 2015; 51(6):610-5. PubMed ID: 26859963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC; Foster-Frey J; Donovan DM
    FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An electro-optical meniscus-sensing system for a pressurized flush bottle.
    Benson RW; Schiebler GL; Krovetz LJ; Sutterer WF
    J Appl Physiol; 1965 May; 20(3):569-70. PubMed ID: 5837580
    [No Abstract]   [Full Text] [Related]  

  • 8. Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin.
    Francius G; Domenech O; Mingeot-Leclercq MP; Dufrêne YF
    J Bacteriol; 2008 Dec; 190(24):7904-9. PubMed ID: 18835985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysostaphin: an antistaphylococcal agent.
    Kumar JK
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS.
    SCHINDLER CA; SCHUHARDT VT
    Proc Natl Acad Sci U S A; 1964 Mar; 51(3):414-21. PubMed ID: 14171453
    [No Abstract]   [Full Text] [Related]  

  • 11. Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies.
    Schaffner W; Melly MA; Hash JH; Koenig MG
    Yale J Biol Med; 1967 Feb; 39(4):215-29. PubMed ID: 5182857
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of lysostaphin.
    Quinn EL; Jones DN; Steinhauer BW; Cox F
    Antimicrob Agents Chemother (Bethesda); 1966; 6():382-8. PubMed ID: 5985262
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus.
    LaPlante KL
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):413-8. PubMed ID: 17141452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.
    Shah A; Mond J; Walsh S
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2704-7. PubMed ID: 15215130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LYSOSTAPHIN: ENZYMATIC MODE OF ACTION.
    BROWDER HP; ZYGMUNT WA; YOUNG JR; TAVORMINA PA
    Biochem Biophys Res Commun; 1965 Apr; 19():383-9. PubMed ID: 14317407
    [No Abstract]   [Full Text] [Related]  

  • 16. A foot-operated laboratory counter.
    Lam-Po-Tang PR; Tyler VJ
    Am J Clin Pathol; 1971 Jul; 56(1):111-6. PubMed ID: 5556208
    [No Abstract]   [Full Text] [Related]  

  • 17. Susceptibility of Staphylococcus epidermidis to lysostaphin and major antimicrobial agents.
    Pulverer G; Jeliaszewicz J
    Chemotherapy; 1973; 19(2):109-14. PubMed ID: 4762803
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.
    Climo MW; Ehlert K; Archer GL
    Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A device for efficient washing of paper disks for gentamicin or other assay procedures.
    Butcher RH
    Am J Clin Pathol; 1977 Nov; 68(5):598-600. PubMed ID: 920659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Standardization of interpretation of microbiologic determination of antibiotics. Use of an electronic calculator. 3. Definition and use of test limits].
    Piguet JD; Pitton JS; Linder A
    Pharm Acta Helv; 1969 Jan; 44(1):54-64. PubMed ID: 5767361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.